The online hub for digital CME and CE courses
The ONA Forum consultants answer your questions
View articles about patient-focused care
October 26, 2012
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
June 22, 2012
What are the benefits of probiotics? Does any particular kind offer more benefits than the others?
An 85% remission rate was noted in a group of patients with acute myeloid leukemia who received the histone deacetylase inhibitor vorinostat in addition to cytarabine and idarubicin.
The IV antimicrobial tigecycline, indicated for the treatment of various infections, targets and destroys leukemia stem cells by cutting off the cell's energy production.
October 21, 2011
Should patients receive a test dose of bleomycin? If yes, should the test dose be administered with every dose or just the initial dose?
The regulatory protein FoxM1 is essential for the continued growth of medulloblastoma and is significantly and negatively correlated with survival, making it a useful prognostic marker.
August 01, 2011
A recently FDA-approved treatment and an experimental BRAF inhibitor offer hope to patients with metastatic melanoma.
August 01, 2011
Ipilimumab is a recombinant, human cytotoxic T-lymphocyte antigen 4-blocking monoclonal antibody indicated for the treatment of unresectable or metastatic melanoma.
April 12, 2011
Treatment-related pain is debilitating for patients. Many medications are not effective, but some techniques can alleviate patients' discomfort.
Prophylactic antibiotics, barrier isolation and air quality control measures can substantially reduce the risk of death in high-risk cancer patients after chemotherapy, a systematic review has shown
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |
